The invention belongs to the technical field of
gene vaccines and particularly relates to a
vibrio mimicus oral target
epitope gene vaccine. The
vibrio mimicus oral target
epitope gene vaccine comprises the following steps: S1, designing a vaccine
target gene OVepis; S2, inserting the vaccine
target gene OVepis designed in the S1 into 261-280bp of a related
peptide fragment area of a II-type molecule in a
protein coding gene CD74 of an immune carrier
grass carp, wherein the direction is from 5'end to 3'end of a sequence; forming a CD74(1-261bp)-Ovepis-CD74(280-711bp) mosaic gene of 1020 bp, loading the mosaic gene by using a freeze-
drying bacterial ghost of
escherichia coli DH5a of a targeted delivery vector, and obtaining the target
epitope gene vaccine. The
nucleotide sequence of the mosaic gene is shown in SEQ ID NO:20. The
vibrio mimicus oral target epitope gene vaccine has the beneficial effects that: the oral target epitope gene vaccine not only prevents the degradation of
nuclease in vivo and increases the expression of
a DNA encoding gene of the vaccine in a local
antigen presenting
cell of a
mucous membrane, but also efficiently transfers an expressed and processed antigenpeptide to cells T and B, so that the immune effect of the vaccine is greatly improved.